In8Bio Q3 2026 Results: Net Loss of $4.59M, Loss Widens
IN8BIO, INC. reported a net loss of $14.5 million for the nine months ended September 30, 2026, which was consistent with the prior year period. The company's cash position decreased significantly from $27.1 million at the end of 2025 to $14.0 million as of September 30, 2026, primarily due to $12.6 million used in operating activities.
- Key figure
- Net loss $4.59M